Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Urbana, Illinois 61801


Purpose:

The purpose of this study is to evaluate clinical and laboratory safety in patients receiving 4 different doses of GVAX® Prostate Cancer Vaccine in order to determine a maximum tolerated dose.


Criteria:

Inclusion Criteria: - Diagnosis of adenocarcinoma of the prostate - Metastatic prostate cancer deemed to be unresponsive or refractory to hormone therapy - Detectable metastases - ECOG performance status of 0 or 1 Exclusion Criteria: - Transitional cell, small cell, neuroendocrine, or squamous cell prostate cancer - Significant cancer related pain - Prior gene therapy, chemotherapy, or immunotherapy


NCT ID:

NCT00140348


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Urbana, Illinois 61801
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.